Still top cause of death, the types of heart disease people are dying from is changing
Peer-Reviewed Publication
In recognition of Heart Health Month, we’re spotlighting the importance of cardiovascular wellness. From risk factors and prevention to innovative treatments, we’re exploring the science and stories shaping heart health today.
Updates every hour. Last Updated: 22-Jul-2025 18:11 ET (22-Jul-2025 22:11 GMT/UTC)
Over the past 50 years, overall heart disease death rates have dropped by 66% and deaths from heart attacks have declined by nearly 90%.
Women who experience severe bleeding after giving birth face elevated risks to their cardiovascular health that can persist for up to 15 years – a new analysis of data from over 9.7 million women across Europe, North America and Asia shows.
Exposure to high levels of the body’s primary stress hormone – cortisol – in preterm fetuses can disrupt normal heart development, potentially increasing the risk of cardiovascular disease in later life.
The study, which was conducted at the Department of Neurology, Inselspital, the University Hospital of Bern, analysed 4,170 individuals over an observation period of 13,217 person-years, found that heart rate variability (HRV) during sleep can serve as a powerful early warning sign of future health conditions, including stroke, depression, and cognitive dysfunction.
A simple intervention, similar to the tension applied to the arm during a blood pressure reading, is being tested to see if it can reduce the risk of heart failure in cancer survivors treated with common cancer drugs, anthracyclines
A phase II clinical trial to test the intervention has already recruited 355 people, with 608 patients across Europe expected to take part across six countries and 22 hospitals
This is the first time an intervention has been offered to cancer patients during their treatment that could reduce their long-term chances of heart failure
3 million Europeans receive anthracyclines as part of their cancer treatment each year. One million people in Europe are currently living with chronic heart failure following cancer therapy-related heart damage, or cardiotoxicity.
The National Heart Centre Singapore (NHCS) and Mayo Clinic have collaborated under a Memorandum of Understanding (MOU) to accelerate cardiovascular innovation and research, and to foster knowledge for future cardiovascular care worldwide. This is a result of a two-day scientific meeting between the two organisations, which is supported by the Tanoto Foundation - an independent family foundation that catalyses system changes in education, healthcare and leadership development.
A study of microplastics in U.S. coastal waters found that residents of counties adjacent to the most heavily microplastic-polluted waters had significantly higher rates of Type 2 diabetes, coronary artery disease (plaque-clogged blood vessels feeding the heart) and stroke compared to similar counties located near waters with low levels of microplastic pollution.